Home » Topics » BioWorld Science

BioWorld Science
RSS

First patient dosed in phase IIb study of Lomecel-B in hypoplastic left heart syndrome

July 7, 2021

Positive interim data from phase Ib study of ARO-HIF2 in clear cell renal cell carcinoma

July 7, 2021

New beta-amyloid PET imaging agent [18F]Flotaza shows promise in Alzheimer's disease brain

July 7, 2021

TruLarv standardized Galleria mellonella developed for screening new antimicrobials

July 7, 2021

DIO2 is a regulator of mitochondrial activity in developing human cardiomyocytes

July 7, 2021

Aston Sci studies AST-021p for advanced solid tumors in phase I

July 7, 2021

BNC-210 advances into phase IIb trial in PTSD

July 6, 2021

HIV rebound biomarkers give insights into controllers and, unexpectedly, comorbidities

July 6, 2021

HUTCHMED initiates phase I study of HMPL-295 in advanced solid tumors

July 6, 2021

Downregulation of ERBB4 leads to peripartum cardiomyopathy

July 6, 2021

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...